Profile
Melita Sun Jung currently works at Terns Pharmaceuticals, Inc., as Chief Business Officer from 2024.
Ms. Jung also formerly worked at Adamas Pharmaceuticals LLC, as Senior Director-Corporate Development from 2014 to 2017, Sangamo Therapeutics, Inc., as Head-Business Development from 2017 to 2021, Ascendancy Healthcare, Inc., as Vice President-Business Development from 2012 to 2014, and Structure Therapeutics, Inc., as Chief Business Officer.
Ms. Jung received her undergraduate degree from the University of California, Berkeley.
Melita Jung active positions
| Companies | Position | Start |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 22/04/2024 |
Former positions of Melita Jung
| Companies | Position | End |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2021 |
| ADAMAS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/06/2017 |
Ascendancy Healthcare, Inc.
Ascendancy Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Engages in the commercialization of pharmaceutical products | Corporate Officer/Principal | 01/05/2014 |
| STRUCTURE THERAPEUTICS INC. | Corporate Officer/Principal | - |
Training of Melita Jung
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Adamas Pharmaceuticals LLC
Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendancy Healthcare, Inc.
Ascendancy Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Engages in the commercialization of pharmaceutical products | Health Technology |
Terns Pharmaceuticals, Inc.
Terns Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small-molecule product candidates to address serious diseases including oncology and obesity | Health Technology |
Structure Therapeutics, Inc.
Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
- Stock Market
- Insiders
- Melita Jung
















